Gita Ramamurthy1, Edgardo Trejo1, Stephen V Faraone1. 1. Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York (Drs Ramamurthy and Faraone); and Department of Psychiatry, Harvard Medical School, Boston, Massachusetts (Dr Trejo).
Abstract
OBJECTIVE: Depression has been linked to adverse coronary artery disease outcomes. Whether depression treatment improves or worsens coronary artery disease prognosis is unclear. This 25-year systematic review examines medical outcomes, and, secondarily, mood outcomes of depression treatment among patients with coronary artery disease. DATA SOURCES: We systematically reviewed the past 25 years (January 1, 1986-December 31, 2011) of prospective trials reporting on the medical outcomes of depression treatment among patients with established coronary artery disease using keywords and MESH terms from OVID MEDLINE. Search 1 combined depression AND coronary artery disease AND antidepressants. Search 2 combined depression AND coronary artery disease AND psychotherapy. Search 3 combined depression AND revascularization AND antidepressants OR psychotherapy. STUDY SELECTION: English-language longitudinal randomized controlled trials, with at least 50 depressed coronary artery disease patients, reporting the impact of psychotherapy and/or antidepressants on cardiac and mood outcomes were included. DATA EXTRACTION: Data extracted included author name, year published, number of participants, enrollment criteria, depression definition/measures (standardized interviews, rating scales), power analyses, description of control arms and interventions (psychotherapy and/or medications), randomization, blinding, follow-up duration, follow-up loss, depression scores, and medical outcomes Results: The review yielded 10 trials. Antidepressant and/or psychotherapy did not significantly influence coronary artery disease outcomes in the overall population, but most studies were underpowered. There was a trend toward worse coronary artery disease outcomes after treatment with bupropion. CONCLUSIONS: After an acute coronary syndrome, depression often spontaneously remitted without treatment. Post-acute coronary syndrome persistence of depression predicted adverse coronary artery disease outcomes. Antidepressant and/or psychotherapy, particularly as part of the Coronary Psychosocial Evaluation Studies intervention, may improve prognosis in persistent depression among post-acute coronary syndrome patients. Noradrenergic antidepressants should be prescribed cautiously in patients with coronary artery disease.
OBJECTIVE:Depression has been linked to adverse coronary artery disease outcomes. Whether depression treatment improves or worsens coronary artery disease prognosis is unclear. This 25-year systematic review examines medical outcomes, and, secondarily, mood outcomes of depression treatment among patients with coronary artery disease. DATA SOURCES: We systematically reviewed the past 25 years (January 1, 1986-December 31, 2011) of prospective trials reporting on the medical outcomes of depression treatment among patients with established coronary artery disease using keywords and MESH terms from OVID MEDLINE. Search 1 combined depression AND coronary artery disease AND antidepressants. Search 2 combined depression AND coronary artery disease AND psychotherapy. Search 3 combined depression AND revascularization AND antidepressants OR psychotherapy. STUDY SELECTION: English-language longitudinal randomized controlled trials, with at least 50 depressed coronary artery diseasepatients, reporting the impact of psychotherapy and/or antidepressants on cardiac and mood outcomes were included. DATA EXTRACTION: Data extracted included author name, year published, number of participants, enrollment criteria, depression definition/measures (standardized interviews, rating scales), power analyses, description of control arms and interventions (psychotherapy and/or medications), randomization, blinding, follow-up duration, follow-up loss, depression scores, and medical outcomes Results: The review yielded 10 trials. Antidepressant and/or psychotherapy did not significantly influence coronary artery disease outcomes in the overall population, but most studies were underpowered. There was a trend toward worse coronary artery disease outcomes after treatment with bupropion. CONCLUSIONS: After an acute coronary syndrome, depression often spontaneously remitted without treatment. Post-acute coronary syndrome persistence of depression predicted adverse coronary artery disease outcomes. Antidepressant and/or psychotherapy, particularly as part of the Coronary Psychosocial Evaluation Studies intervention, may improve prognosis in persistent depression among post-acute coronary syndromepatients. Noradrenergic antidepressants should be prescribed cautiously in patients with coronary artery disease.
Authors: Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-02-23 Impact factor: 29.690
Authors: Marlene P Freeman; Maurizio Fava; James Lake; Madhukar H Trivedi; Katherine L Wisner; David Mischoulon Journal: J Clin Psychiatry Date: 2010-06 Impact factor: 4.384
Authors: François Lespérance; Nancy Frasure-Smith; Diana Koszycki; Marc-André Laliberté; Louis T van Zyl; Brian Baker; John Robert Swenson; Kayhan Ghatavi; Beth L Abramson; Paul Dorian; Marie-Claude Guertin Journal: JAMA Date: 2007-01-24 Impact factor: 56.272
Authors: Johan Denollet; Elisabeth J Martens; Ivan Nyklícek; Viviane M Conraads; Beatrice de Gelder Journal: Health Psychol Date: 2008-05 Impact factor: 4.267
Authors: Peter de Jonge; Adriaan Honig; Joost P van Melle; Aart H Schene; Astrid M G Kuyper; Dorien Tulner; Annique Schins; Johan Ormel Journal: Am J Psychiatry Date: 2007-09 Impact factor: 18.112
Authors: Thomas Rutledge; Viola Vaccarino; B Delia Johnson; Vera Bittner; Marian B Olson; Sarah E Linke; Carol E Cornell; Wafia Eteiba; David S Sheps; Jennifer Francis; David S Krantz; C Noel Bairey Merz; Susmita Parashar; Eileen Handberg; Diane A Vido; Leslee J Shaw Journal: J Am Coll Cardiol Date: 2009-01-13 Impact factor: 24.094
Authors: William Whang; Laura D Kubzansky; Ichiro Kawachi; Kathryn M Rexrode; Candyce H Kroenke; Robert J Glynn; Hasan Garan; Christine M Albert Journal: J Am Coll Cardiol Date: 2009-03-17 Impact factor: 27.203
Authors: Hannes Bielas; Rebecca E Meister-Langraf; Jean-Paul Schmid; Jürgen Barth; Hansjörg Znoj; Ulrich Schnyder; Mary Princip; Roland von Känel Journal: J Clin Med Date: 2022-04-21 Impact factor: 4.964